Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von PapaSmurf 

Cardinal Health Inc. diskutieren

Cardinal Health Inc.

WKN: 880206 / Symbol: CAH / Name: Cardinal Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /

168,85 €
0,27 %

Einschätzung Buy
Rendite (%) 34,11 %
Kursziel 173,85
Veränderung
Endet am 13.08.26

Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Robert W. Baird from $197.00 to $203.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,67 %
Kursziel 159,51
Veränderung
Endet am 06.10.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $186.00 to $187.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,09 %
Kursziel 190,12
Veränderung
Endet am 31.10.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at Evercore ISI from $190.00 to $220.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,18 %
Kursziel 195,19
Veränderung
Endet am 03.11.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at TD Cowen from $183.00 to $225.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,68 %
Kursziel 192,29
Veränderung
Endet am 05.11.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at Wells Fargo & Company from $185.00 to $221.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,54 %
Kursziel 182,39
Veränderung
Endet am 08.11.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at Argus from $189.00 to $211.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,70 %
Kursziel 198,15
Veränderung
Endet am 17.11.26

Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $211.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat